ChemPartner PharmaTech Co.,Ltd. (SHE:300149)
China · Delayed Price · Currency is CNY 8.32
-0.31 (-3.59%)
At close: Jun 2, 2026
ChemPartner PharmaTech Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | 13.55 | -226.47 | -916.75 | 378.59 | -402.25 |
Depreciation & Amortization | 117.28 | 130.09 | 139.62 | 192.79 | 194.33 |
Other Amortization | 46.17 | 49.45 | 50.37 | 55.54 | 54.4 |
Loss (Gain) From Sale of Assets | 0.04 | -8.43 | 0 | 0.15 | 0.02 |
Asset Writedown & Restructuring Costs | -1.81 | 160.75 | 867.18 | 545.29 | 373.27 |
Loss (Gain) From Sale of Investments | -12.15 | -7.8 | 0.92 | -1,391 | -11.05 |
Provision & Write-off of Bad Debts | - | 31.24 | 4.66 | 16.6 | 5.33 |
Other Operating Activities | 40.31 | 23.52 | 44.03 | 32.93 | 85.79 |
Change in Accounts Receivable | -89.4 | 58.81 | 78.67 | -107.3 | 64.96 |
Change in Inventory | 5.92 | 7.01 | 0.06 | -16.49 | -17.13 |
Change in Accounts Payable | 23.39 | -41.24 | -88.55 | 575.2 | 29.69 |
Change in Other Net Operating Assets | 54.08 | - | - | - | - |
Operating Cash Flow | 190.5 | 168.21 | 150.99 | 262.46 | 378.22 |
Operating Cash Flow Growth | 13.25% | 11.40% | -42.47% | -30.61% | 10.22% |
Capital Expenditures | -62.47 | -69.25 | -201.29 | -336.2 | -286 |
Sale of Property, Plant & Equipment | 0.18 | 0.16 | 0.14 | 0.61 | 0.41 |
Divestitures | - | - | 36.82 | 1,590 | 10 |
Investment in Securities | 38.35 | 1.19 | 150.92 | -163.65 | -15.62 |
Other Investing Activities | -45.96 | 0.23 | 0.59 | -82.7 | 80.32 |
Investing Cash Flow | -69.9 | -67.67 | -12.82 | 1,008 | -210.89 |
Long-Term Debt Issued | 21 | 58.45 | 107.95 | 368.3 | 394.77 |
Long-Term Debt Repaid | -47.53 | -141.41 | -490.05 | -1,183 | -549.98 |
Net Debt Issued (Repaid) | -26.53 | -82.96 | -382.1 | -815.08 | -155.21 |
Repurchase of Common Stock | - | - | - | -5.06 | -20.44 |
Common Dividends Paid | -2.9 | -2.88 | -6.24 | -37.4 | -81.14 |
Other Financing Activities | -50.28 | -0.6 | - | -2.56 | -2.56 |
Financing Cash Flow | -79.71 | -86.44 | -388.34 | -860.11 | -259.36 |
Foreign Exchange Rate Adjustments | 1.15 | 7.12 | 6.98 | 22.3 | -0.81 |
Net Cash Flow | 42.03 | 21.22 | -243.19 | 432.43 | -92.84 |
Free Cash Flow | 128.03 | 98.96 | -50.3 | -73.74 | 92.22 |
Free Cash Flow Growth | 29.37% | - | - | - | - |
Free Cash Flow Margin | 11.28% | 10.20% | -4.42% | -5.56% | 5.46% |
Free Cash Flow Per Share | 0.29 | 0.20 | -0.10 | -0.15 | 0.19 |
Cash Interest Paid | - | 0.6 | - | - | - |
Cash Income Tax Paid | -13.64 | -25.41 | 12.02 | -26.33 | -0.98 |
Levered Free Cash Flow | 104.98 | 51.11 | -76.32 | -190.37 | 75.59 |
Unlevered Free Cash Flow | 104.98 | 67.42 | -56.76 | -148.82 | 124.79 |
Change in Working Capital | -12.89 | 15.86 | -39.04 | 431.57 | 78.38 |